1. Home
  2. JJSF vs SUPN Comparison

JJSF vs SUPN Comparison

Compare JJSF & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • SUPN
  • Stock Information
  • Founded
  • JJSF 1971
  • SUPN 2005
  • Country
  • JJSF United States
  • SUPN United States
  • Employees
  • JJSF N/A
  • SUPN N/A
  • Industry
  • JJSF Specialty Foods
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JJSF Consumer Staples
  • SUPN Health Care
  • Exchange
  • JJSF Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • JJSF 2.3B
  • SUPN 2.0B
  • IPO Year
  • JJSF N/A
  • SUPN 2012
  • Fundamental
  • Price
  • JJSF $112.80
  • SUPN $42.16
  • Analyst Decision
  • JJSF Buy
  • SUPN Buy
  • Analyst Count
  • JJSF 2
  • SUPN 2
  • Target Price
  • JJSF $142.50
  • SUPN $41.00
  • AVG Volume (30 Days)
  • JJSF 177.4K
  • SUPN 1.0M
  • Earning Date
  • JJSF 08-05-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • JJSF 2.77%
  • SUPN N/A
  • EPS Growth
  • JJSF N/A
  • SUPN 1411.53
  • EPS
  • JJSF 4.29
  • SUPN 1.14
  • Revenue
  • JJSF $1,599,746,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • JJSF $3.51
  • SUPN N/A
  • Revenue Next Year
  • JJSF $3.44
  • SUPN $15.74
  • P/E Ratio
  • JJSF $26.24
  • SUPN $37.00
  • Revenue Growth
  • JJSF 0.49
  • SUPN 5.55
  • 52 Week Low
  • JJSF $106.40
  • SUPN $29.16
  • 52 Week High
  • JJSF $180.80
  • SUPN $43.62
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 47.53
  • SUPN 75.52
  • Support Level
  • JJSF $106.40
  • SUPN $40.26
  • Resistance Level
  • JJSF $115.18
  • SUPN $42.96
  • Average True Range (ATR)
  • JJSF 4.30
  • SUPN 1.72
  • MACD
  • JJSF -0.15
  • SUPN 0.62
  • Stochastic Oscillator
  • JJSF 28.02
  • SUPN 87.53

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: